Aptose Biosciences, Laxai Avanti Life Sciences deal

Aptose partnered with CRO Laxai Avanti Life Sciences to develop next-generation epigenetic-based therapies. Laxai will optimize multiple clinical candidates from Aptose, including candidates to treat ...